134 related articles for article (PubMed ID: 8887170)
1. Human aging and the GH-IGF-I axis.
Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
[TBL] [Abstract][Full Text] [Related]
2. Somatopause reflects age-related changes in the neural control of GH/IGF-I axis.
Giordano R; Lanfranco F; Bo M; Pellegrino M; Picu A; Baldi M; Balbo M; Bonelli L; Grottoli S; Ghigo E; Arvat E
J Endocrinol Invest; 2005; 28(3 Suppl):94-8. PubMed ID: 16042366
[TBL] [Abstract][Full Text] [Related]
3. GHRH and GH secretagogues: clinical perspectives and safety.
Aimaretti G; Baldelli R; Corneli G; Bellone S; Rovere S; Croce C; Ragazzoni F; Giordano R; Arvat E; Bona G; Ghigo E
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():86-92. PubMed ID: 16456487
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span.
Ghigo E; Arvat E; Gianotti L; Lanfranco F; Broglio F; Aimaretti G; Maccario M; Camanni F
J Pediatr Endocrinol Metab; 2000; 13 Suppl 6():1493-502. PubMed ID: 11202226
[TBL] [Abstract][Full Text] [Related]
5. Associated hormonal decline in aging: is there a role for GH therapy in aging men?
Lombardi G; Di Somma C; Rota F; Colao A
J Endocrinol Invest; 2005; 28(3 Suppl):99-108. PubMed ID: 16042367
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing peptides.
Ghigo E; Arvat E; Muccioli G; Camanni F
Eur J Endocrinol; 1997 May; 136(5):445-60. PubMed ID: 9186261
[TBL] [Abstract][Full Text] [Related]
7. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing.
D'Costa AP; Ingram RL; Lenham JE; Sonntag WE
J Reprod Fertil Suppl; 1993; 46():87-98. PubMed ID: 8315618
[TBL] [Abstract][Full Text] [Related]
8. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
[TBL] [Abstract][Full Text] [Related]
9. Differential responses of the growth hormone axis in two rat models of streptozotocin-induced insulinopenic diabetes.
Kim E; Sohn S; Lee M; Jung J; Kineman RD; Park S
J Endocrinol; 2006 Feb; 188(2):263-70. PubMed ID: 16461552
[TBL] [Abstract][Full Text] [Related]
10. The age-related down-regulation of the growth hormone/insulin-like growth factor-1 axis in the elderly male is reversed considerably by donepezil, a drug for Alzheimer's disease.
Obermayr RP; Mayerhofer L; Knechtelsdorfer M; Mersich N; Huber ER; Geyer G; Tragl KH
Exp Gerontol; 2005 Mar; 40(3):157-63. PubMed ID: 15763392
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone deficiency (GHD) in adult thalassaemic patients.
Scacchi M; Danesi L; Cattaneo A; Valassi E; Pecori Giraldi F; Argento C; D'Angelo E; Mirra N; Carnelli V; Zanaboni L; Cappellini MD; Cavagnini F
Clin Endocrinol (Oxf); 2007 Nov; 67(5):790-5. PubMed ID: 17608814
[TBL] [Abstract][Full Text] [Related]
12. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
13. Is the somatopause an indication for growth hormone replacement?
Savine R; Sönksen PH
J Endocrinol Invest; 1999; 22(5 Suppl):142-9. PubMed ID: 10442584
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone-releasing hormone and growth hormone-releasing peptide as therapeutic agents to enhance growth hormone secretion in disease and aging.
Thorner MO; Chapman IM; Gaylinn BD; Pezzoli SS; Hartman ML
Recent Prog Horm Res; 1997; 52():215-44; discussion 244-6. PubMed ID: 9238854
[TBL] [Abstract][Full Text] [Related]
15. Ageing, growth hormone and physical performance.
Lanfranco F; Gianotti L; Giordano R; Pellegrino M; Maccario M; Arvat E
J Endocrinol Invest; 2003 Sep; 26(9):861-72. PubMed ID: 14964439
[TBL] [Abstract][Full Text] [Related]
16. Human growth hormone and human aging.
Corpas E; Harman SM; Blackman MR
Endocr Rev; 1993 Feb; 14(1):20-39. PubMed ID: 8491152
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity.
Maccario M; Tassone F; Grottoli S; Rossetto R; Gauna C; Ghigo E
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 1):140-4. PubMed ID: 11994678
[TBL] [Abstract][Full Text] [Related]
18. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
Rubinek T; Modan-Moses D
Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
[TBL] [Abstract][Full Text] [Related]
19. [IGF-1 receptors in the brain control longevity in mice].
Holzenberger M
Med Sci (Paris); 2009 Apr; 25(4):371-6. PubMed ID: 19409189
[TBL] [Abstract][Full Text] [Related]
20. The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis.
Perrini S; Laviola L; Carreira MC; Cignarelli A; Natalicchio A; Giorgino F
J Endocrinol; 2010 Jun; 205(3):201-10. PubMed ID: 20197302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
